Key Points: The video demonstrates the key principles of the oligonucleotide model, released in V23 of the Simcyp Simulator. The tutorial shows how to set up an oligonucleotide compound, what are the model options for drug distribution, elimination and target binding. Additionally, the PK model for an oligonucleotide can be linked to the PD.
Certara accelerates medicines to patients using proprietary biosimulation software and technology to transform traditional drug discovery and development. Its clients include 1,600 global biopharmaceutical companies, leading academic institutions, and key regulatory agencies across 60 countries.
Please visit us at www.certara.com/